Certificates
Certificates of Analysis
Review available third-party laboratory reports for selected 805 Peptides products.
Tirzepatide 20 mg
Assay: 99.79%
Report: TOA202608WX2024
Approval date: September 7, 2026
Result: Pass
View CertificateTesamorelin 20 mg
Assay: 99.76%
Report: TOA202608WX2014
Approval date: August 29, 2026
Result: Pass
View CertificateSS-31 50 mg
Assay: 99.83%
Report: TOA202608WX2013
Approval date: August 29, 2026
Result: Pass
View CertificateARA290 (Cibinetide) 10 mg
Assay: 99.65%
Report: TOA202608WX2015
Approval date: August 30, 2026
Result: Pass
View CertificateTirzepatide 40 mg
Assay: 99.71%
Report: TOA202608WX2016
Approval date: August 30, 2026
Result: Pass
View CertificateSemax 10 mg
Assay: 99.69%
Report: TOA202608WX2018
Approval date: August 30, 2026
Result: Pass
View CertificateSelank 10 mg
Assay: 99.59%
Report: TOA202608WX2019
Approval date: September 7, 2026
Result: Pass
View CertificateDIhexa 10 mg
Assay: 99.48%
Report: TOA202608WX2011
Approval date: August 29, 2026
Result: Pass
View CertificateKLOW 80 mg
Assay: 99.93%
Report: TOA202609WX2005
Approval date: September 20, 2026
Result: Pass
View CertificateL-carnitine 10 ml
Assay: 99.93%
Report: TOA202609WX2009
Approval date: September 20, 2026
Result: Pass
View CertificateNAD+ 1000 mg
Assay: 99.86%
Report: TOA202609WX2004
Approval date: September 20, 2026
Result: Pass
View CertificatePinealon 20 mg
Assay: 99.74%
Report: TOA202609WX2003
Approval date: September 20, 2026
Result: Pass
View CertificateRelaxatlonPM
Assay: 99.88%
Report: TOA202609WX2008
Approval date: September 20, 2026
Result: Pass
View CertificateRetatrutide 30 mg
Assay: 99.75%
Report: TOA202609WX2001
Approval date: September 19, 2026
Result: Pass
View CertificateLaboratory reports are provided for reference to the tested samples identified in each report. Review the full certificate for test methods, limits, results, and report-specific qualifications.